发明名称 |
METHODS FOR IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS RECEIVING CANCER THERAPY |
摘要 |
PROBLEM TO BE SOLVED: To provide identification of predictive markers that can be used to clinically determine whether patients with cancer are responsive or non-responsive to a therapeutic regimen prior to treatment.SOLUTION: In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, where the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers included in a marker set, it is possible to determine whether a therapeutic agent, or a combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.SELECTED DRAWING: None |
申请公布号 |
JP2016101174(A) |
申请公布日期 |
2016.06.02 |
申请号 |
JP20160023487 |
申请日期 |
2016.02.10 |
申请人 |
MILLENNIUM PHARMACEUTICALS INC |
发明人 |
BRYANT BARBARA M;DAMOKOSH ANDREW I;MULLIGAN GEORGE |
分类号 |
C12N15/09;A61P35/02;C12M1/00;C12M1/34;C12Q1/02;C12Q1/04;C12Q1/68;G01N33/53;G01N33/574;G06Q50/00 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|